Skip to main content
. 2020 Jul 1;190(1):41–57. doi: 10.1007/s11845-020-02264-w

Fig. 5.

Fig. 5

Dendritic cell (DC) vaccines. (1) Gather peripheral blood mononuclear cells. (2) Produce immature DCs using a cytokine cocktail. (3) Loading tumour-derived antigens onto DC. (4) Inject vaccine comprising activated antigen-presenting DCs into the patient. (5) Vaccine triggers anti-tumour immune effector cell responses leading to T cell- and NK cell-mediated tumour killing